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Small bowel malignancies are rare neoplasms, usually inaccessible to conventional endoscopy but detectable in many cases by cross-
sectional imaging. Modern multidetector computed tomographies permit accurate diagnosis, complete pretreatment staging, and follow-
up of these lesions. In this review, we describe the cross-sectional imaging features of the most frequent histologic subtypes of the small
bowel malignancies.Resume
Les tumeurs malignes de l’intestin gre^le sont des neoplasmes rares, habituellement que l’on ne peut discerner au moyen d’une endoscopie
classique, mais qui bien souvent peuvent se detecter a l’aide de l’imagerie transversale. La tomodensitometrie multi-barrette moderne permet
d’etablir un diagnostic precis, de proceder a une stadification complete avant le traitement et d’effectuer le suivi de ces lesions. Dans la
presente analyse, nous decrivons les caracteristiques que possedent, sur les examens d’imagerie transversale, les sous-types histologiques de
tumeurs de l’intestin gre^le les plus communs.
 2012 Canadian Association of Radiologists. All rights reserved.
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Small bowel neoplasms are uncommon and account for
less than 5% of all gastrointestinal (GI) tract malignancies
[1e4]. They are often associated with high mortality because
tumour-related symptoms are often nonspecific and occur
late in the clinical course. Typical clinical symptoms include
partial or complete obstruction, weight loss, evidence of
blood loss, and abdominal mass [1]. Less common symptoms
include diarrhoea, weakness, fever, and pallor [1]. Because
of their inaccessibility by conventional endoscopy, imaging
plays an important role in diagnosis. Traditionally, barium
studies have been considered the standard imaging test for
neoplasms of the small bowel [1,3]. More recently, multi-
detector computed tomography (MDCT) has shown
increasing importance for detection, preoperative staging of
tumour extension through the bowel wall, nodal* Address for correspondence: Margaret Fraser-Hill, MDCM, FRCPC, The
Ottawa Hospital, Civic Campus, 1053 Carling Ave, Ottawa, Ontario K1Y
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doi:10.1016/j.carj.2010.10.001involvement, and distant metastases, and for follow-up after
treatment to detect recurrent or metastatic disease. In many
cases, distinct morphologic features on cross-sectional imag-
ing allow accurate prediction of tumour histology [3e14]. In
this review, we present the cross-sectional imaging features
of the most frequent histologic subtypes of malignant small
bowel neoplasms.Adenocarcinoma
The annual incidence of small bowel adenocarcinoma in
the United States has been estimated to be 3.9 cases per
million people, with peak age of presentation between 60 and
70 years [15]. Adenocarcinoma accounts for 30%-50% of all
small bowel malignancies [16e18]. The majority of these
neoplasms are located in the duodenum (54%), followed by
the jejunum (28%), and the ileum (18%) [17,18]. The higher
incidence in the duodenum is thought to be related to the
higher concentration of bile and its metabolites, which are
implicated as possible carcinogens [17]. Like colon cancer,
small bowel adenocarcinoma develops from an adenomatousll rights reserved.
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elevated risk of developing large bowel adenocarcinomas,
and vice versa [17]. Risk factors for small bowel adenocar-
cinoma include cigarette smoking, alcohol use, prior peptic
ulcer disease, familial adenomatous polyposis, hereditary
nonpolyposis colorectal cancer, celiac disease, and cystic
fibrosis [15e18]. The risk of small bowel adenocarcinoma in
familial adenomatous polyposis is estimated to be 50-300
times the general population [18]. Crohn disease also is an
important risk factor [17,18]. The risk for patients with
Crohn disease is estimated to be 43-100 times greater than
the average population [18]. Crohn associated adenocarci-
nomas tend to occur in the ileum, which reflects the
distribution of disease [17].
Patients with small bowel adenocarcinoma typically
present in their 6th or 7th decade with obstruction, weight
loss, anemia, rectal bleeding, and palpable mass [1]. Disease
is more common in men than women [18]. Symptoms may
be vague and result in delayed diagnosis, by which time
tumours are often metastatic.
The accuracy of conventional computed tomography
(CT) for diagnosis of small bowel tumours has been
reported to be approximately 47% [16]. It is important to
note that lesions smaller than 2 cm are frequently missed,
especially by older single-slice CT technology that had
neither the spatial nor temporal resolution of modern
MDCT. The accuracy of modern MDCT for the diagnosis of
small bowel adenocarcinoma has yet to be determined. CT
is advantageous over conventional barium studies for
detection of extramucosal spread, lymphadenopathy, and
distant metastases [5]. CT features of adenocarcinoma are
similar to those seen on barium studies and include short,
sharply demarcated filling defect, eccentric thickening, or
circumferential stenosis. Abrupt transition and irregular
shouldered overhanging margins are typical [1,5].
Obstruction is a common feature of small bowel adeno-
carcinoma [1]. Adenocarcinomas of the distal small bowel
tend to be annular, whereas duodenal lesions tend to be
papillary or polypoid [5]. After intravenous contrast
administration, these mucosal-based soft-tissue lesions
demonstrate enhancement (Figure 1) [5]. Ulceration may be
present in 40% of cases [1]. Large lesions may occasionally
be mistaken for lymphoma; however, nodal metastases are
less bulky in adenocarcinoma [2,5,6]. Metastases to regional
lymph nodes and invasion of the mesenteric vessels occur
relatively early and can present as stranding of the mesen-
teric fat, obliteration of fat planes, as well as nodular lesions
greater than 4 mm in size (Figure 1) [5].
Carcinoid Tumour
Carcinoid tumours arise from argentaffin endocrine amine
precursor uptake and decarboxylation Kulchitsky cells in the
base of the crypts of Lieberk€uhn, found throughout the GI
tract and in other organs, such as the lung and pancreas [1,
7]. Carcinoid tumours represent approximately 2% of all
GI tract malignancies and the second most common primarysmall bowel malignancy, with a predominance in woman
[19,20]. Whereas, most carcinoid tumours arise sporadically,
syndromic carcinoid tumours are seen with type 1 and 2
multiple endocrine neoplasm (MEN) and type 1 neurofibro-
matosis [21]. They are also reported with increased
frequency in hereditary nonpolyposis colorectal carcinoma
[18]. Overall, GI tract carcinoid tumours occur most
frequently in the appendix (50%). The small bowel is the
next most common site (33%), most commonly in the ileum,
followed by the jejunum [1,8].
Small intestinal carcinoid tumours are usually asymp-
tomatic when small and confined to the bowel. Tumours
become symptomatic when large enough to encroach upon
the bowel lumen or when they metastasize to lymph nodes or
the liver. Symptoms arise from both the local and systemic
effects of these lesions. Local symptoms vary from vague to
crampy abdominal pain, abdominal distension, nausea,
vomiting, fatigue, and weight loss [1,21]. The classic
presentation of systemic carcinoid syndrome includes signs
and symptoms of flushing of the face and neck, hypotension,
tachycardia, secretory diarrhoea, telangiectasia, bronchial
constriction, peptic ulceration, and right-sided cardiac
lesions, and occurs in only 10% of patients. Systemic
carcinoid syndrome may also be associated with bronchial
carcinoids and tumours in other locations [1,9]. Metastatic
disease, predominantly to the liver, is found in 80% of
patients with the syndrome [21]. The likelihood of metas-
tases correlates to primary tumour size. Lesions smaller than
1 cm have nodal and liver metastases in fewer than 30% of
patients. For tumours of 1-2 cm in size, this increases to
60%-80% for nodal metastases and 10% for liver metastases.
Tumours larger than 2 cm have nodal metastases in 80% and
liver metastases in 40%-50% [7].
Radiologic findings depend upon the size and location of the
tumour (Figure 2). Small bowel series and fluoroscopic enter-
oclysis were used before the era of cross-sectional imaging
[1,9].ModernMDCTscanners,which allow thinner collimation
and faster scanning, can sometimes identify small tumours as
avidly enhancing submucosal lesions. Detection is improved if
water is given as an oral contrast and multiplanar reconstruc-
tions are performed. Low attenuation oral contrast permits
optimal delineation of enhancing tumour against the bowel
lumen. Dual-phase (arterial and venous) imaging allows
optimal imaging of the arteries and veins. CT enteroclysis with
multiplanar reconstruction has advantages of enteroclysis with
morphologic imaging capabilities of helical CT, which lead to
an improved detection rate. In a recent study, MDCT detected
small bowel carcinoids with a sensitivity of 100% and speci-
ficity of 96.2% [9]. Whereas, CTmay not always identify small
tumours, it is excellent at demonstrating mesenteric extension
and liver metastases. Carcinoid metastases to the liver are
typically hypervascular on early arterial images, showing avid
enhancement and becoming isoattenuating to the liver paren-
chyma on delayed phases [7]. Mesenteric metastases produce
a well-defined soft-tissue mass with radiating linear densities
that cause a stellate or spoke-wheel configuration. This is
thought to occur secondary to fibrosis, with extension of tumour
Figure 1. Adenocarcinoma. (A, B, C) A 56-year-old man who presented with persistent vomiting and weight loss. Endoscopy revealed a tight stenosis of the
duodenum. (A) Contrast-enhanced computed tomography (CT) images show abnormal dilatation of the proximal duodenum (asterisk), abrupt transition to
a stenotic mass in the third stage (m) (black arrows) with lobulated intraluminal margin, ill-defined outer margin, and multiple surrounding small solid lymph
nodes (white arrows). (B) There are multiple small, peripherally-enhancing solid liver metastases. (C) T2-weighted coronal magnetic resonance image of
a similar stenotic, ‘‘apple core’’ duodenal adenocarcinoma (white arrows) in another patient. (D) Crohn disease with obstructing jejunal adenocarcinoma.
Contrast-enhanced CT showing small bowel obstruction from a solid, stenotic mass (arrow) with lobulated intraluminal margin, thick enhancing mucosal layer,
abrupt transition, and shouldered margin.
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teric vessels may be involved either directly because of
encasement or narrowing, or indirectly because of the produc-
tion of neuroendocrine chemicals and their effect on the vessel
wall [7,20], and, when involved, fibrosis, ischemia, and oedema
can occur, which results in a thickened bowel wall [21]. Calci-
fications occur in up to 70% of metastatic mesenteric masses.
Conditions potentially confused with carcinoid include treated
lymphoma and retractile mesenteritis [10]. Definitive diagnosis
may not be possible before surgery for signs and symptoms of
obstruction.Obstruction is usually not from the tumour itself but
is secondary to mesenteric desmoplastic reaction and subse-
quent kinking of the bowel [11,22,23].
Lymphoma
Non-Hodgkin lymphoma accounts for 1%-4% of GI tract
malignancies [24]. Of these, 35%-50% involve the small
bowel. Lymphomas originate from the lymphoid follicles of
the submucosa [25]. The ileum is the most frequentlyaffected, because of its abundance of lymphatic tissue.
Lesions are frequently multiple (34%) and involve different
segments (18%) or the same segment (16%) of the small
bowel. More than 77% of lesions exceed 5 cm in diameter,
and the average length of diseased bowel is 12 cm [2].
The majority of GI lymphomas are of B-cell origin from
mucosa-associated lymphoid tissue. Subtypes include immu-
noproliferative small intestinal disease (or Mediterranean
type), mantle cell lymphoma, Burkitt lymphoma, follicular
and lymphocytic lymphoma, and immunodeficiency-
associated lymphoma [26]. Mantle cell lymphoma is seen in
adults older than 50 years, and mainly occurs in the terminal
ileum and is characterized by numerous polypoid or masslike
solid lesions. Burkitt lymphomas tend to occur in children at
the ileocecal region. They are associated with the Epstein-Barr
virus but also HIV/AIDS. Follicular and lymphocytic
lymphomas also tend to occur in the ileocecal region. T-cell
lymphomas are uncommon and are often associated with
celiac disease. The jejunum is commonly involved and may
demonstrate multiple ulcerated lesions [26].
Figure 2. Carcinoid tumour. (A, B) Axial and coronal computed tomography (CT) images show a small, lobulated mesenteric mass containing punctate
calcifications and showing surrounding retractile desmoplastic fibrosis (white arrows). The primary bowel lesion was not seen. (C, D) This elderly, cachectic
woman presented with multiple, increasingly frequent and prolonged episodes of bowel obstruction. CT scan (C) and abdominal plain film (D) show severely
distended bowel from chronic obstruction. Contrast-enhanced CT (C) shows absence of subcutaneous and intra-abdominal fat, severe generalized small bowel
dilatation, static intraluminal contents, and solid enhancing mass (white arrows) at the point of transition to normal calibre collapsed small bowel in the pelvis.
Surgically confirmed carcinoid tumour.
218 D. D. Fernandes et al. / Canadian Association of Radiologists Journal 63 (2012) 215e221Although primary GI tract lymphoma can present acutely
because of perforation or obstruction, the presentation is
often more insidious. Patients can present with abdominal
pain, nausea and/or vomiting, anorexia, malaise, bleeding,
anemia, diarrhoea, or constipation [1,26,27].
Various morphologic forms have been described based on
their cross-sectional findings (Figure 3). Lymphoma may
present as a nodular filling defect, a polyp that may be the
lead point of an intussusception, a long distensible infil-
trating lesion with thickened walls with or without aneu-
rysmal dilatation, or a large exoenteric mass that extends to
the adjacent tissues [27,28]. In most cases, small bowel
lymphoma appears as a large, segmental nodular wall
thickening. There is a gradual transition from bulky tumour
to normal mucosa [6]. The bowel wall may often be asym-
metrically thickened and can mimic adenocarcinoma. Themain discriminating feature is the presence of bulky aden-
opathy in lymphoma (Figure 3) [4,6]. The next most
common pattern is that of a polypoid lesion that may present
as the lead point of an intussusception. Infiltrating
lymphomas tend to produce ill-defined, thickened walls with
irregular or complete loss of normal mucosal folds. The
junction of tumour with normal mucosa is more gradual and
difficult to define compared with adenocarcinoma. Obstruc-
tion is rare because the tumour weakens the muscularis
propria, which results in dilatation [5]. This has been termed
‘‘aneurysmal dilatation’’ and is present in nearly 50% of
cases [3]. Aneurysmal dilatation is caused by the infiltration
of the muscularis propria and destruction of the autonomic
nerve plexus by the lymphomatous cells, which cause the
bowel to lose its tone and to dilate focally. The last pattern is
that of a large exoenteric mass that extends beyond the bowel
Figure 3. Lymphoma. This middle-aged man presented with right lower quadrant discomfort. Ultrasound (A) and unenhanced computed tomography (B) reveal
a solid, homogeneous right lower quadrant mass (A and B, white star). There was bulky, homogeneous adenopathy (C, white arrows) and abnormal thickening
of multiple ileal loops without obstruction (D, black arrows).
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fistulous tracts with adjacent loops of bowel [6].
GI Stromal Tumour
GI stromal tumour (GIST) is the most common non-
epithelial tumour of the GI tract and occurs most frequently in
the stomach (60%) and small bowel (20%-30%) [29,30] GIST
includes many tumours previously designated as leiomyoma,
cellular leiomyoma, leiomyoblastoma, and leiomyosarcoma
[29]. GIST is believed to originate from the intestinal cells of
Cajal or their stem-cell precursors [30]. Cajal cells are inter-
mediates between the GI tract autonomic nervous system and
smooth-muscle cells that regulate GI tract motility and auto-
nomic nerve function. They are located around the myenteric
plexus and in the muscularis propria throughout the GI tract
[30]. Like the intestinal cells of Cajal from which they arise,
the majority of GIST tumours stain positive at immunohisto-
chemistry for vimentin and c-Kit (CD 117) [29]. The majority
of GISTs can be classified as spindle cell type (70%), epithe-
lioid type (20%), or mixed [29,31,32].
GISTs are frequently discovered incidentally during
imaging, surgery, or at autopsy [29]. The most common
presentation of GIST is bleeding. Acute abdominal pain may
arise from tumour rupture or obstruction, and mimic acute
appendicitis (Figure 4) [30]. The peak age of onset is in the6th decade [33]. At diagnosis, up to 30% of newly diagnosed
GISTs are overtly malignant or demonstrate high malignant
potential [30]. Syndromic GIST occurs in neurofibromatosis
type 1 and familial GIST syndrome. In neurofibromatosis
type 1, they tend to occur in the small intestine and are often
multiple. With familial GIST, inheritance is autosomal
dominant, and multiple diffuse GISTs develop. The Carney
triad consists of gastric GIST, paraganglioma, pulmonary
chondroma, or both [30].
The radiographic features of GIST are similar to imaging
features described previously for leiomyomas or leiomyo-
sarcomas (Figure 4) [1,12]. GIST appears as a well-
circumscribed mass that compresses adjacent organs and
lacks a true capsule [12,13]. Because GIST involves the outer
muscular layer of the bowel wall, there is a propensity for
exophytic growth in 45%e86% [12,13,31]. GISTs can reach
a large size, yet they rarely present with obstruction [12].
Mucosal ulceration is seen on the luminal surface in up to
50% of cases, and patients often present with GI tract
bleeding [12,13].
On contrast-enhanced CT scans, peripheral enhancement
is seen in large tumours. A central area of low attenuation
usually corresponds to hemorrhage and/or necrosis. In some
cases, the central area of low attenuation may represent the
tumour itself, cystic degeneration, or fluid in an ulcer.
Extensive necrosis and fistula formation may occur, which
Figure 4. Gastrointestinal stromal tumour (GIST). (A-D) This 44-year-old man presented with abdominal distention and pain. (A) Contrast-enhanced computed
tomography (CT) shows a dumbbell-shaped, heterogeneously enhancing mass originating from small bowel (white arrows). Magnetic resonance imaging
coronal T1-weighted (B), coronal T2-weighted (C), and axial contrast-enhanced (D) images show a heterogeneous solid mass with central necrosis,
hemorrhage and heterogeneous enhancement (D, white arrow). (E) A 53-year-old man presented with acute abdominal pain, peritonitis and suspected
appendicitis. Contrast-enhanced CT (E) shows a cavitated mid-abdominal soft-tissue mass containing gas and fluid, with surrounding inflammation and trace
ascites. The wall of the lesion is irregular anteriorly where it was found to be perforated at surgery.
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present with large ulcerated or cavitary masses, however,
they tend to be associated with bulky lymphadenopathy
[4,6,12]. Metastases are seen in up to 50% of GISTs and
predominantly involve the liver and the peritoneum. When
present, they tend to be hypervascular. Ascites is uncommon,
because these tumours do not produce a significant inflam-
matory reaction [14]. Lymph node metastases and extra-
abdominal disease are seen in only advanced cases [33].Figure 5. Metastatic disease. Melanoma metastases to the small bowel. (A) Ar
vascular enhancing submucosal nodular lesions (white arrows). (B) Venous phase
point for jejunojejunal intussusception (white arrow). There are also solid superfi
gluteal region (white arrowheads).Metastases to the Small Bowel
Overall, metastatic disease is the most commonmalignancy
to involve the small bowel [6]. Hematogenous metastases most
frequently arise from primary lesions of the lung, breast,
kidneys, and skin (melanoma) [6]. Metastatic disease may also
present as bulky mesenteric masses, which mimic lymphoma,
or rarely, as focal bowel wall thickening, similar to adenocar-
cinoma.Clinical history assists to distinguishmetastatic lesionsterial phase computed tomography (CT) scan shows multiple small, hyper-
CT scan in the same patient shows a larger metastatic deposit acting as a lead
cial fascial metastatic deposits in the left anterior abdominal wall and right
221Imaging of small bowel malignancies / Canadian Association of Radiologists Journal 63 (2012) 215e221from small bowel adenocarcinoma or lymphoma [6]. Mela-
noma is responsible for 25%-33% of intestinal metastases [2].
They often present as smooth, round-to-polypoid masses that
cause transient intussusception rather than complete obstruc-
tion (Figure 5) [34]. In the duodenum, target lesions with
central ulceration may be seen. Lung metastases may be flat or
polypoid and frequently ulcerate. Bowel metastases from
breast cancer usually manifest as submucosal lesions in the
duodenum [4]. Mucinous tumours of the ovary, appendix, and
colon are the most common tumours to spread by intraperito-
neal seeding [4]. Implants occur along the peritoneal linings,
with a propensity to develop at the areas of relative fluid stasis,
such as in the pouch of Douglas, ileocolic region, sigmoid
mesocolon, and paracolic gutters [4]. On CT, peritoneal seed-
ing appears as multifocal, discontinuous nodularity along the
small bowel serosa, mesentery, and omentum; bowel-wall
thickening; infiltration of the mesenteric or intraperitoneal
fat; fixation; and kinking of bowel. Bowel obstruction is
a frequent complication. Although mesenteric masses and
stranding are nonspecific, history and clinical findings can
distinguish metastatic disease from other entities [4]. Pancre-
atic, biliary, and colonic tumoursmay directly involve the small
bowel by contiguous extension. CT is excellent in depicting
extension of disease into adjacent organs and soft tissues [4].
Summary
Malignancies of the small bowel are rare and are often
discovered late in their clinical course. MDCT has recently
become a powerful tool in the diagnosis of these lesions,
which allows for diagnostic characterization of the lesion,
prediction of histology, staging of regional and distant
spread, and follow-up after treatment. A precise diagnosis
can often be suggested from imaging alone as cross-sectional
features correlate well with a histologic subtype. Because
early diagnosis often provides the best hope for cure, when
faced with unexplained GI tract blood loss, bowel obstruc-
tion, pain, weight loss, or other abdominal complaints for
which a cause cannot be found, small bowel malignancies
should be considered and investigated with MDCT. This will
facilitate timely and effective management.
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